Defense Advanced Research Projects AgencyTagged Content List

Infectious Disease

Relating to ailments caused by pathogens

Showing 55 results for Disease RSS
March 2, 2017,
Doubletree by Hilton San Diego Downtown
DARPA’s Biological Technologies Office is hosting a Proposers Day meeting to provide information to potential applicants on the structure and objectives of the new Pandemic Prevention Platform (P3) program. P3 aims to develop an integrated, end-to-end platform that uses nucleic acid sequences to halt the spread of viral infections in 60 days or less. Performers will use nucleic-acid-based technologies pioneered by DARPA as a foundation for work to overcome the remaining bottlenecks preventing rapid response to pandemic threats.
June 13, 2018,
Westin Arlington Gateway Hotel
DARPA’s Biological Technologies Office is hosting a Proposers Day meeting to provide information to potential applicants on the structure and objectives of the new PReemptive Expression of Protective Alleles and Response Elements (PREPARE) program. PREPARE will explore ways to better protect against biological, chemical, or radiological threats by temporarily and reversibly tuning gene expression to bolster the body’s defenses against—or directly neutralize—a given threat. It will focus on four key health challenges as proofs of concept: influenza viral infection, opioid overdose, organophosphate poisoning, and exposure to gamma radiation.
January 30, 2018,
Executive Conference Center
DARPA’s Biological Technologies Office is hosting a Proposers Day meeting to provide information to potential applicants on the structure and objectives of the new Preventing Emerging Pathogenic Threats (PREEMPT) program. PREEMPT aims to predict and contain viral mutations to prevent cross-species transmission of viral infectious disease from animals and insects to humans.
June 27, 2016,
Offsite
DARPA’s Biological Technologies Office (BTO) is hosting a Proposers Day to provide information to potential proposers on the objectives of the upcoming Prometheus program. The program aims to discover host prognostic biomarkers of acute respiratory infection that predict if a person will become contagious after infection, but prior to the onset of symptoms. A key aspect of the program will be to characterize human immune responses at multiple time points during infection.
May 17, 2019,
Executive Conference Center
The Biological Technologies Office is holding a Proposers Day meeting to provide information to potential proposers on the objectives of the new ReVector program and to facilitate teaming. The goal of ReVector is to develop an easily delivered treatment — for example, a topical solution — that safely and temporarily modifies the human skin microbiome to alter scents and thereby reduce attraction of disease-spreading mosquitoes.